Shares of Jazz Pharmaceuticals (NASDAQ:JAZZ) have been halted from trading pending news. Rumors are circulating that the company was being bought out by Pfizer (NYSE:PFE). SmarTrend is bullish on shares of Jazz Pharmaceuticals and our subscribers were alerted to buy on December 23, 2011 at $38.75. The stock has risen 20.4% since the alert was issued.
